152 related articles for article (PubMed ID: 9034354)
1. Significance of IgG for the activity of factor XII measured in human plasma.
Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
[TBL] [Abstract][Full Text] [Related]
2. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
Hoem NO; Johannesen S; Briseid K
Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
[TBL] [Abstract][Full Text] [Related]
3. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
[TBL] [Abstract][Full Text] [Related]
4. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
Wuillemin WA; Furlan M; Stricker H; Lämmle B
Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
[TBL] [Abstract][Full Text] [Related]
6. A site on factor XII required for productive interactions with polyphosphate.
Shamanaev A; Litvak M; Cheng Q; Ponczek M; Dickeson SK; Smith SA; Morrissey JH; Gailani D
J Thromb Haemost; 2023 Jun; 21(6):1567-1579. PubMed ID: 36863563
[TBL] [Abstract][Full Text] [Related]
7. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
[TBL] [Abstract][Full Text] [Related]
8. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor XII protease domain crystal structure.
Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic properties of activated FXII.
Braat EA; Dooijewaard G; Rijken DC
Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
[TBL] [Abstract][Full Text] [Related]
11. Part of prekallikrein removed from human plasma together with IgG--immunoblot experiments and functional tests.
Briseid K; Hoem NO; Johannesen S
Scand J Clin Lab Invest; 1999 Feb; 59(1):55-63. PubMed ID: 10206098
[TBL] [Abstract][Full Text] [Related]
12. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
Lämmle B; Berrettini M; Griffin JH
Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
[TBL] [Abstract][Full Text] [Related]
13. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
Briseid K; Lygren I; Johannesen S; Marthinsen K
Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
15. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
Hoem NO; Johannesen S; Briseid K
Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
[TBL] [Abstract][Full Text] [Related]
16. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
Briseid K; Hoem NO; Johannesen S; Haug K
Thromb Res; 1995 May; 78(3):239-50. PubMed ID: 7631304
[TBL] [Abstract][Full Text] [Related]
17. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
18. Contributions of contact activation pathways of coagulation factor XII in plasma.
Chatterjee K; Guo Z; Vogler EA; Siedlecki CA
J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791
[TBL] [Abstract][Full Text] [Related]
19. Functional correlation between kallikrein and factor XII activated in human plasma.
Briseid K; Hoem NO; Johannesen S; Marthinsen K
Thromb Res; 1990 Mar; 57(6):945-56. PubMed ID: 1696402
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
